We found that 1q21 gain is common (45.9%) at diagnosis in multiple myeloma, and this aberration is associated with later ISS stage levels, lower serum albumin levels, and elevated LDH concentrations, consistent with previous research results (3, 8, 16). This evidence concerns the gene ALB and plasma cell myeloma.